PPIDT00015
Drug Information
| Name | Reteplase |
|---|---|
| Sequence | SYQGNSDCYFGNGSAYRGTHSLTESGASCLPWNSMILIGKVYTAQNPSAQALGLGKHNYCRNPDGDAKPWCHVLKNRRLTWEYCDVPSCSTCGLRQYSQPQFRIKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERFPPHHLTVILGRTYRVVPGEEEQKFEVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTVCLPPADLQLPDWTECELSGYGKHEALSPFYSERLKEAHVRLYPSSRCTSQHLLNRTVTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVCLNDGRMTLVGIISWGLGCGQKDVPGVYTKVTNYLDWIRDNMRP |
| DrugBank_ID | DB00015 |
| Type | biotech |
| Indication | For lysis of acute pulmonary emboli, intracoronary emboli, and management of myocardial infarction. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| — | — |
10 U
|
| Injection, powder, for solution | Intravenous |
10 U
|
| Injection, powder, lyophilized, for solution | Intravenous |
|
| Injection, powder, lyophilized, for solution; kit | Intravenous |
1.81 mg/1mL
|
| Kit | Intravenous |
1.81 mg/1mL
|
| Powder, for solution | Intravenous |
10.4 unit / vial
|
| Injection, powder, lyophilized, for solution | Intravenous |
1800000 mg
|